Medical and Pharmaceutical New York doctor warns that change in fingernails can be linked to lung cancer He says anyone who notices it, even without other symptoms, should seek medical attention Rowan DunneAugust 7, 2025
Health & Wellness New Fraunhofer technology promises lower radiation in cancer imaging Radar technology has long played a vital role in aviation and automotive industries Joseph MortonAugust 6, 2025
Medical and Pharmaceutical Giant inflatable lungs help promote cancer detection in United Kingdom They will make an appearance to help celebrate the Cambridge debut of a national screening program Rowan DunneAugust 5, 2025
AI and Autonomy Offline AI tool could transform skin cancer diagnosis in remote areas Ensuring the system's resilience in low-resource environments has been a core design priority Joseph MortonJuly 30, 2025
AI and Autonomy New Lyme test detects disease early with 90% accuracy It uses a machine-learning algorithm to analyze the immune response, detecting patterns unique to each individual Joseph MortonJuly 29, 2025
Medical and Pharmaceutical Hong Kong lung cancer survivor advocates for AI-powered screening measures Artificial intelligence has the power to cut healthcare costs associated with lung cancer screening in half, he highlighted Rowan DunneJuly 28, 2025
Medical and Pharmaceutical bioAffinity Technologies obtains Canadian patent for lung cancer spit test The CyPath Lung screening tool is also patented in China, Australia and Japan Rowan DunneJuly 22, 2025
Medical and Pharmaceutical Medpace Holdings stock just popped by 50%, but why? Medpace delivered a standout Q2, with revenue rising 14.2 per cent year-over-year to USD$603.3 million Joseph MortonJuly 22, 2025
Medical and Pharmaceutical American researcher anticipates robust growth for e-nose market Market.US is one of multiple that believe the breath analysis industry will be expanding significantly Rowan DunneJuly 17, 2025
Medical and Pharmaceutical Cizzle Bio submits NIH grant proposal for biomarker blood test for lung cancer The study will analyze pre-diagnostic and longitudinal blood plasma samples from the PLCO Cancer Screening Trial Joseph MortonJuly 14, 2025